235 related articles for article (PubMed ID: 1968931)
21. Vasoactive intestinal polypeptide in relation to penile erection in the cat evoked by pelvic and hypogastric nerve stimulation.
Andersson PO; Björnberg J; Bloom SR; Mellander S
J Urol; 1987 Aug; 138(2):419-22. PubMed ID: 2885430
[TBL] [Abstract][Full Text] [Related]
22. [Role of nitric oxide in the erectile mechanism].
Alberti C; Frattini A; Ferretti S
Minerva Urol Nefrol; 1993 Jun; 45(2):49-54. PubMed ID: 7694379
[TBL] [Abstract][Full Text] [Related]
23. [Metaraminol--an antidote in corpus cavernosum autoinjection therapy-induced prolonged erection].
Stief CG; Gilbert P; Wetterhauer U; Bähren W; Thon W; Altwein JE
Urologe A; 1986 May; 25(3):164-5. PubMed ID: 2426857
[TBL] [Abstract][Full Text] [Related]
24. Regulation of pre-synaptic alpha adrenergic activity in the corpus cavernosum.
Saenz de Tejada I; Kim NN; Goldstein I; Traish AM
Int J Impot Res; 2000 Mar; 12 Suppl 1():S20-25. PubMed ID: 10845761
[TBL] [Abstract][Full Text] [Related]
25. Systemic and cavernous plasma levels of vasoactive intestinal polypeptide during sexual arousal in healthy males.
Becker AJ; Uckert S; Stief CG; Scheller F; Knapp WH; Machtens SA; Kuczyk MA; Jonas U
World J Urol; 2002 May; 20(1):59-63. PubMed ID: 12088193
[TBL] [Abstract][Full Text] [Related]
26. Nitric oxide and penile erectile function.
Toda N; Ayajiki K; Okamura T
Pharmacol Ther; 2005 May; 106(2):233-66. PubMed ID: 15866322
[TBL] [Abstract][Full Text] [Related]
27. Concentrations of vasoactive intestinal polypeptide in corpus cavernosum and peripheral venous blood during prostaglandin E1-induced erection.
Koehn FM; Miska W; Schill WB; Weidner W; Weiske WH
Arch Androl; 1993; 31(3):217-22. PubMed ID: 8274048
[TBL] [Abstract][Full Text] [Related]
28. Pharmacology of penile erection.
Andersson KE
Pharmacol Rev; 2001 Sep; 53(3):417-50. PubMed ID: 11546836
[TBL] [Abstract][Full Text] [Related]
29. Involvement of noradrenergic innervation from locus coeruleus to hippocampal formation in negative feedback regulation of penile erection in the rat.
Chang AY; Huang CM; Chan JY; Chan SH
Hippocampus; 2001; 11(6):783-92. PubMed ID: 11811673
[TBL] [Abstract][Full Text] [Related]
30. Gene transfer of vasoactive intestinal polypeptide into the penis improves erectile response in the diabetic rat.
Shen ZJ; Wang H; Lu YL; Zhou XL; Chen SW; Chen ZD
BJU Int; 2005 Apr; 95(6):890-4. PubMed ID: 15794804
[TBL] [Abstract][Full Text] [Related]
31. Pharmacologic treatment of impotence.
Malloy TR; Malkowicz B
Urol Clin North Am; 1987 May; 14(2):297-305. PubMed ID: 2883750
[TBL] [Abstract][Full Text] [Related]
32. Effect of vasoactive intestinal peptide and acetylcholine on penile erection in the rat in vivo.
Suh JK; Mun KH; Cho CK; Shin HC; Kim YS; Park TC
Int J Impot Res; 1995 Jun; 7(2):111-8. PubMed ID: 7496439
[TBL] [Abstract][Full Text] [Related]
33. Endothelium-dependency of yohimbine-induced corpus cavernosum relaxation.
Filippi S; Luconi M; Granchi S; Natali A; Tozzi P; Forti G; Ledda F; Maggi M
Int J Impot Res; 2002 Aug; 14(4):295-307. PubMed ID: 12152120
[TBL] [Abstract][Full Text] [Related]
34. Cytotoxicity of different intracavernous vasoactive drugs on cultured endothelial cells of human corpus cavernosum penis.
Schultheiss D; Pilatz A; Gabouev AI; Schlote N; Wefer J; Mertsching H; Sohn M; Jonas U; Stief CG
Urology; 2004 Sep; 64(3):598-602. PubMed ID: 15351616
[TBL] [Abstract][Full Text] [Related]
35. A pilot study of the role of intracavernous injection of vasoactive intestinal peptide (VIP) and phentolamine mesylate in the treatment of erectile dysfunction.
McMahon CG
Int J Impot Res; 1996 Dec; 8(4):233-6. PubMed ID: 8981173
[TBL] [Abstract][Full Text] [Related]
36. Pharmacotherapy in erectile dysfunction agents for self-injection programs and alternative application models.
Hedlund H; Hedlund P
Scand J Urol Nephrol Suppl; 1996; 179():129-38. PubMed ID: 8908679
[TBL] [Abstract][Full Text] [Related]
37. [Intracavernous injection of vasoactive drugs for treating erectile impotence].
Yasumoto R; Asakawa M; Kawashima H; Yoshimura R; Maekawa T; Kashiwara N; Tanaka H; Nishio S
Hinyokika Kiyo; 1988 Feb; 34(2):301-4. PubMed ID: 2454019
[TBL] [Abstract][Full Text] [Related]
38. The role of vasoactive intestinal polypeptide as a neurotransmitter in canine penile erection: a combined in vivo and immunohistochemical study.
Juenemann KP; Lue TF; Luo JA; Jadallah SA; Nunes LL; Tanagho EA
J Urol; 1987 Oct; 138(4):871-7. PubMed ID: 2888903
[TBL] [Abstract][Full Text] [Related]
39. [Action of vasoactive drugs in male sexual impotence].
Morales JC; Elizondo B
Arch Esp Urol; 1989; 42(9):900-4. PubMed ID: 2624491
[TBL] [Abstract][Full Text] [Related]
40. Systemic and cavernosal plasma levels of endothelin (1-21) during different penile conditions in healthy males and patients with erectile dysfunction.
Becker AJ; Uckert S; Stief CG; Truss MC; Hartmann U; Jonas U
World J Urol; 2001 Nov; 19(5):371-6. PubMed ID: 11760787
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
